Singhe Hospitals PLC
CCSELK:SINH.N000021.50
LKR
-0.50
(-2.27%)
ISIN
LK0440N00004
Return %
Stock
S&P 500
1Y
88.60
14.39
3Y
795.83
81.42
5Y
667.86
68.62
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Amarakone M. Weerasinghe
- Full Time Employees
- 602
- Sector
- Health services
- Industry
- Hospital/Nursing management
- Address
- Ratnapura Sri Lanka
- IPO Date
- Feb 18, 2015
- Website
- singhehospital.com
- Similar Companies
- Business
- Singhe Hospitals PLC is a Sri Lanka-based healthcare services provider engaged in operating multi-specialty tertiary care hospitals, medical diagnostic laboratories, and retail pharmacies. Founded in 2009 and headquartered in Ratnapura, Sri Lanka, the company delivers comprehensive healthcare solutions primarily across the Sabaragamuwa Province and expanding regional markets. Singhe Hospitals PLC operates through three principal business segments: Hospital Services, Laboratory Services, and Retail Pharmacies. Its core healthcare offerings include 24-hour emergency treatment unit (ETU) operations; intensive care unit (ICU) and neonatal intensive care unit (NICU) management; inpatient admissions across general wards and private luxury rooms; outpatient clinical consultations across multiple medical disciplines; surgical operations spanning general surgery, laparoscopic surgery, orthopedic surgery, obstetrics and gynecology, urology, ENT surgery, pediatric surgery, and ophthalmology; renal dialysis care; and dental procedures. Its diagnostic and laboratory services encompass fully automated clinical laboratory testing across biochemistry, hematology, microbiology, immunology, clinical pathology, and histopathology; digital radiology and imaging services including computerized tomography (CT) scanning, digital X-ray, 2D and 4D ultrasound, mammography, and echocardiography; and endoscopy and colonoscopy diagnostics, supported by an extensive regional network of medical laboratory collection centers. The company's retail division operates in-house dispensaries and standalone outlets under the Singhe Pharmacy brand, distributing prescription pharmaceuticals, over-the-counter medicines, surgical supplies, and health and wellness consumer products. In recent developments, Singhe Hospitals PLC has broadened its geographical footprint by expanding its network of diagnostic sample collection centers and rolling out additional standalone Singhe Pharmacy outlets across key regional commercial hubs. The company has also accelerated its digital transformation through the deployment of online diagnostic reporting portals, digital patient engagement platforms, and modernized hospital information management systems. Furthermore, Singhe Hospitals PLC has undertaken targeted capital investments to upgrade diagnostic imaging equipment, expand specialty clinical capacities, and strengthen pharmaceutical procurement strategies to ensure operational resilience and supply chain continuity.